Compagnie Lombard Odier S Cm A Bristol Myers Squibb CO Transaction History

Compagnie Lombard Odier S Cm A

$6.12 Billion
Q3 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 240,435 shares of BMY stock, worth $12.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

240,435

Previous 240,435 -0.0%

Holding current value

$12.8 Million

Previous $9.99 Million 24.61%

% of portfolio

0.2%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$47.98 - $54.4 $8.42 Million - $9.54 Million	175,400 Added 269.7%	240,435 $13 Million
Q4 2023 Jan 16, 2024	BUY	$48.48 - $57.85 $3.03 Million - $3.62 Million	62,600 Added 2570.84%	65,035 $3.34 Million
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $115,780 - $129,460	2,000 Added 459.77%	2,435 $141,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $169 - $99,892	-1,300 Reduced 74.93%	435 $31,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $63,939 - $76,668	-1,040 Reduced 37.48%	1,735 $127,000
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $22,256 - $25,945	415 Added 17.58%	2,775 $173,000
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $177,510 - $207,930	-3,000 Reduced 55.97%	2,360 $140,000
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $72,125 - $78,544	1,165 Added 27.77%	5,360 $358,000
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $9,791 - $11,012	-165 Reduced 3.78%	4,195 $265,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $906,518 - $1.03 Million	-15,700 Reduced 78.27%	4,360 $270,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $457,717 - $507,210	7,970 Added 65.92%	20,060 $1.21 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $747,968 - $1.09 Million	-16,120 Reduced 57.14%	12,090 $675,000
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $39,712 - $51,801	-807 Reduced 2.78%	28,210 $1.81 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $128,310 - $152,130	-3,000 Reduced 9.37%	29,017 $1.47 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $861,969 - $953,150	19,318 Added 152.12%	32,017 $1.45 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $12.1 Million - $14.4 Million	-267,400 Reduced 95.47%	12,699 $605,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $638,707 - $828,249	13,099 Added 4.91%	280,099 $14.6 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $99,342 - $112,050	-1,800 Reduced 0.67%	267,000 $16.6 Million
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $1.51 Million - $1.88 Million	29,800 Added 12.47%	268,800 $14.9 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $1.59 Million - $1.83 Million	-26,470 Reduced 9.97%	239,000 $15.1 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $113,886 - $124,164	1,900 Added 0.72%	265,470 $16.3 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $303,765 - $350,570	5,500 Added 2.13%	263,570 $16.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	258,070	258,070 $14.4 Million

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account

Compagnie Lombard Odier S Cm A Bristol Myers Squibb CO Transaction History